Evaluation of a 30-gene paclitaxel, fluorouracil, doxorubicin and cyclophosphamide chemotherapy response predictor in a multicenter randomized trial in breast cancer

PURPOSE: We examined in a prospective, randomized, international clinical trial the performance of a previously defined 30-gene predictor (DLDA-30) of pathologic complete response (pCR) to preoperative weekly paclitaxel and fluorouracil, doxorubicin, cyclophosphamide (T/FAC) chemotherapy, and assess...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Tabchy, Adel, Valero, Vicente, Vidaurre, Tatiana, Lluch, Ana, Gomez, Henry, Martin, Miguel, Qi, Yuan, Barajas-Figueroa, Luis Javier, Souchon, Eduardo, Coutant, Charles, Doimi, Franco D, Ibrahim, Nuhad K, Gong, Yun, Hortobagyi, Gabriel N, Hess, Kenneth R, Symmans, W Fraser, Pusztai, Lajos
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4181852/
https://ncbi.nlm.nih.gov/pubmed/20829329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-10-1265
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados